Counterfeit BP medicine racket busted
Analysis based on 7 articles · First reported Aug 27, 2026 · Last updated Aug 27, 2026
The bust may temporarily affect the reputation of KC Pharmaceuticals, but the company is a victim and likely to recover. The counterfeit drug trade poses a risk to public health and could lead to stricter regulatory oversight in the pharmaceutical distribution chain.
The Ahmedabad City Crime Branch, in a joint operation with the India — Gujarat India — Food and Drugs Control Administration, arrested three individuals allegedly involved in the manufacture, procurement, and interstate distribution of counterfeit blood pressure medication. The investigation began after KC Pharmaceuticals Limited filed a complaint on August 19 regarding counterfeit NICARDIA RETARD 10 tablets. The counterfeit stock was traced through medical agencies in Ahmedabad, Lucknow, and Jaipur. Three suspects were arrested on August 26. The case is registered under various sections of the Bharatiya Nyaya Sanhita, 2023, and further arrests are expected.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard